Manuel Muñoz-Torres

Summary

Publications

  1. pmc Development of a new tool for assessing health-related quality of life in patients with primary hyperparathyroidism
    Susan M Webb
    Department of Medicine Endocrinology, Hospital Sant Pau, Pare Claret 167, Barcelona, Spain
    Health Qual Life Outcomes 11:97. 2013
  2. pmc Atherosclerotic disease in type 2 diabetes is associated with an increase in sclerostin levels
    Sonia Morales-Santana
    Bone Metabolic Unit, Red Temática de Investigación Cooperativa en Envejecimiento y Fragilidad, Endocrinology Division, Hospital Universitario San Cecilio, Granada, Spain
    Diabetes Care 36:1667-74. 2013
  3. doi request reprint Results from a national survey on the management of primary hyperparathyroidism
    M Munoz Torres
    Hospital Universitario San Cecilio, Granada, Spain
    J Endocrinol Invest 35:957-63. 2012
  4. doi request reprint Circulating levels of sclerostin are increased in patients with type 2 diabetes mellitus
    Antonia García-Martín
    Bone Metabolic Unit, Endocrinology Division, Hospital Universitario San Cecilio, Avenida Dr Oloriz 16, 18012 Granada, Spain
    J Clin Endocrinol Metab 97:234-41. 2012
  5. doi request reprint Role of serum FSH measurement on bone resorption in postmenopausal women
    Antonia García-Martín
    Bone Metabolic Unit, Endocrinology Division, Hospital Universitario San Cecilio, Avenida Doctor Olóriz 16, 18012 Granada, Spain
    Endocrine 41:302-8. 2012
  6. doi request reprint [Wnt pathway and sclerostin as new targets for assessment and treatment of osteoporosis]
    Guillermo Alonso
    Unidad de Metabolismo Oseo, Servicio de Endocrinologia y Nutricion, Hospital Universitario San Cecilio, Granada, Espana
    Med Clin (Barc) 139:634-9. 2012
  7. doi request reprint [Effect of milk product with soy isoflavones on quality of life and bone metabolism in postmenopausal Spanish women: randomized trial]
    Antonia García-Martín
    Servicio de Endocrinologia y Nutricion, Hospital Universitario San Cecilio, Granada, Espana
    Med Clin (Barc) 138:47-51. 2012
  8. doi request reprint Serum levels of bone resorption markers are decreased in patients with type 2 diabetes
    Rebeca Reyes-García
    Bone Metabolic Unit, RETICEF, Endocrinology Division, Hospital Universitario San Cecilio, Granada, Spain
    Acta Diabetol 50:47-52. 2013
  9. doi request reprint Serum 25 OH vitamin D concentrations and calcium intake are low in patients with prostate cancer
    Mariela Varsavsky
    Unidad de Metabolismo Oseo, Endocrinologia, Hospital Universitario San Cecilio, Granada, Spain
    Endocrinol Nutr 58:487-91. 2011
  10. doi request reprint Serum osteoprotegerin and sex steroid levels in patients with prostate cancer
    Mariela Varsavsky
    Bone Metabolic Unit RETICEF, Endocrinology Division, Hospital Universitario San Cecilio, Avda Dr Olóriz 16, 18012 Granada, Spain
    J Androl 33:594-600. 2012

Collaborators

  • Rebeca Reyes-García
  • M Munoz Torres
  • J A Amado
  • Antonia García-Martín
  • Pedro Rozas-Moreno
  • Mariela Varsavsky
  • Sonia Morales-Santana
  • Guillermo Alonso
  • Diego Fernández-García
  • Susan M Webb
  • Beatriz García-Fontana
  • Arantzazu Sebastián-Ochoa
  • María Cortés-Berdonces
  • Carles Villabona
  • José Antonio García-Salcedo
  • Jordi Farrerons
  • Xavier Badia
  • Manel Puig-Domingo
  • José Miguel García-Castro
  • Guillermo Alonso Garcia
  • Juristo Fonollá Joya
  • Fernando Escobar-Jimenez
  • Jose A Garcia-Salcedo
  • Guillermo Alonso-Garcia
  • Miguel Quesada Charneco
  • Jose Luis Mijan
  • Pedro Mezquita-Raya
  • Alejandro Alvárez Guisado
  • Maria Dolores Avilés Perez
  • José Juan Jiménez Moleón
  • Amanda Rocío González Ramírez
  • Miguel Quesada-Charneco
  • Inés Luque-Fernández

Detail Information

Publications15

  1. pmc Development of a new tool for assessing health-related quality of life in patients with primary hyperparathyroidism
    Susan M Webb
    Department of Medicine Endocrinology, Hospital Sant Pau, Pare Claret 167, Barcelona, Spain
    Health Qual Life Outcomes 11:97. 2013
    ..The aim of this research is to describe the development of a new disease specific Quality of Life (QoL) questionnaire for use specifically with PHPT patients...
  2. pmc Atherosclerotic disease in type 2 diabetes is associated with an increase in sclerostin levels
    Sonia Morales-Santana
    Bone Metabolic Unit, Red Temática de Investigación Cooperativa en Envejecimiento y Fragilidad, Endocrinology Division, Hospital Universitario San Cecilio, Granada, Spain
    Diabetes Care 36:1667-74. 2013
    ..However, there are few data regarding the sclerostin levels and vascular disease. Our aim was to examine the relationship between serum sclerostin and atherosclerotic disease (AD) in type 2 diabetes mellitus (T2DM)...
  3. doi request reprint Results from a national survey on the management of primary hyperparathyroidism
    M Munoz Torres
    Hospital Universitario San Cecilio, Granada, Spain
    J Endocrinol Invest 35:957-63. 2012
    ..At the Third International Workshop on PHPT, recent data on this disease were reviewed and new clinical recommendations were developed. There are few data on the influence of new guidelines in clinical practice...
  4. doi request reprint Circulating levels of sclerostin are increased in patients with type 2 diabetes mellitus
    Antonia García-Martín
    Bone Metabolic Unit, Endocrinology Division, Hospital Universitario San Cecilio, Avenida Dr Oloriz 16, 18012 Granada, Spain
    J Clin Endocrinol Metab 97:234-41. 2012
    ..Diabetes mellitus is a risk factor for osteoporotic fractures. Sclerostin is an inhibitor of bone formation. However, there are no data about sclerostin levels in type 2 diabetes mellitus (T2DM)...
  5. doi request reprint Role of serum FSH measurement on bone resorption in postmenopausal women
    Antonia García-Martín
    Bone Metabolic Unit, Endocrinology Division, Hospital Universitario San Cecilio, Avenida Doctor Olóriz 16, 18012 Granada, Spain
    Endocrine 41:302-8. 2012
    ..Moreover, the rise in FSH appears to contribute to higher bone resorption. Our results suggest that the measurement of FSH could be usefulness to perform a more comprehensive assessment of bone loss in these women...
  6. doi request reprint [Wnt pathway and sclerostin as new targets for assessment and treatment of osteoporosis]
    Guillermo Alonso
    Unidad de Metabolismo Oseo, Servicio de Endocrinologia y Nutricion, Hospital Universitario San Cecilio, Granada, Espana
    Med Clin (Barc) 139:634-9. 2012
    ..Next, we briefly review the main data about their endogenous antagonist, sclerostin, precisely where drug research is more advanced...
  7. doi request reprint [Effect of milk product with soy isoflavones on quality of life and bone metabolism in postmenopausal Spanish women: randomized trial]
    Antonia García-Martín
    Servicio de Endocrinologia y Nutricion, Hospital Universitario San Cecilio, Granada, Espana
    Med Clin (Barc) 138:47-51. 2012
    ..To analyze the effects of nutritional intervention with a milk product enriched with soy isoflavones on quality of life and bone metabolism in postmenopausal Spanish women...
  8. doi request reprint Serum levels of bone resorption markers are decreased in patients with type 2 diabetes
    Rebeca Reyes-García
    Bone Metabolic Unit, RETICEF, Endocrinology Division, Hospital Universitario San Cecilio, Granada, Spain
    Acta Diabetol 50:47-52. 2013
    ..Lower levels of PTH may induce a low turnover state as reflected by lower levels of bone resorption markers, and this situation may influence the higher risk of fracture of T2DM...
  9. doi request reprint Serum 25 OH vitamin D concentrations and calcium intake are low in patients with prostate cancer
    Mariela Varsavsky
    Unidad de Metabolismo Oseo, Endocrinologia, Hospital Universitario San Cecilio, Granada, Spain
    Endocrinol Nutr 58:487-91. 2011
    ..To evaluate dietary calcium intake (DCI) and vitamin D serum concentrations in patients with prostate cancer...
  10. doi request reprint Serum osteoprotegerin and sex steroid levels in patients with prostate cancer
    Mariela Varsavsky
    Bone Metabolic Unit RETICEF, Endocrinology Division, Hospital Universitario San Cecilio, Avda Dr Olóriz 16, 18012 Granada, Spain
    J Androl 33:594-600. 2012
    ..Future prospective studies are needed to clarify the role of OPG in androgen deprivation therapy-mediated bone loss...
  11. doi request reprint Adiponectin and leptin serum levels in osteoporotic postmenopausal women treated with raloxifene or alendronate
    Arantzazu Sebastián-Ochoa
    Endocrinology Division, Hospital Universitario San Cecilio, Granada, Spain
    Menopause 19:172-7. 2012
    ....
  12. doi request reprint An unusual association of neuroendocrine tumors in MEN 1A
    Mariela Varsavsky
    Bone Metabolic Unit, Endocrinology Department, Hospital Universitario San Cecilio, Av Dr Oloriz 16, 18012, Granada, Spain
    Pituitary 15:393-7. 2012
    ..Now, 2 years later, she continues with normal calcium and i-PTH levels. This report represents an unusual case of MEN 1A with association of insulinomas, gastrinomas glucagonomas and somatostatinomas in the same patient...
  13. doi request reprint [Cardiovascular disease and bone metabolism]
    Rebeca Reyes-García
    Unidad de Metabolismo Oseo, Servicio de Endocrinologia, Hospital Universitario San Cecilio, Granada, Espana
    Endocrinol Nutr 58:353-9. 2011
    ..In addition, recent data suggest the influence of bone metabolism on energy balance which may be relevant for cardiovascular disease...
  14. ncbi request reprint [Anabolic therapy of osteoporosis]
    Diego Fernández-García
    Servicio de Endocrinologia y Nutricion, Hospital Universitario San Cecilio, Granada, Spain
    Med Clin (Barc) 125:341-5. 2005
    ..Two further agents with major evidences of efficacy include strontium ranelate and parathyroid hormone (PTH) and its fragments. The present work reviews the current evidences of anabolic agents used in the treatment of osteoporosis...
  15. doi request reprint Osteocalcin as a marker of metabolic risk in healthy postmenopausal women
    Antonia García-Martín
    Bone Metabolic Unit, Endocrinology Division, San Cecilio University Hospital, Granada, Spain
    Menopause 18:537-41. 2011
    ..Several studies have reported the role of osteocalcin on glucose and fat metabolism. In this study, we analyzed the relationship between the concentration of osteocalcin and metabolic risk factors in healthy postmenopausal women...